Smad4 deletion in blood vessel endothelial cells promotes ovarian cancer metastasis.

SMAD4 is a critical co-smad in signal transduction pathways activated in response to transforming growth factor-β (TGF-β)-related ligands, regulating cell growth and differentiation. The roles played by SMAD4 inactivation in tumors highlighted it as a tumor-suppressor gene. Herein, we report that loss of SMAD4 expression in vascular endothelial cells promotes ovarian cancer invasion. SiRNA transfer of this gene in the HUVEC reduced SMAD4 protein expression and function. Although it reduced the vessel endothelial cell tubule formation in vitro and in vivo, it did not affect the tumor growth significantly in vivo. However, it weakened the barrier integrity in endothelial cells and increased vessel permeability and the ovarian cancer liver metastasis. We documented reduced angiogenesis and increased invasion histologically and by intravital microscopy, and gained mechanistic insight at the messenger and gene level. Finally, we found a negative reciprocal regulation between SMAD4 and FYN. FYN is one of the Src family kinases (SFK), activation of which can cause dissociation of cell-cell junctions and adhesion, resulting in paracellular hypermeability. Upon SMAD4 deletion, we detected high expression levels of FYN in vessel endothelial cells, suggesting the mechanism of the ovarian tumor cells cross the endothelial barrier and transform to an invasive phenotype.

[1]  M. Goumans,et al.  Deficiency for endoglin in tumor vasculature weakens the endothelial barrier to metastatic dissemination , 2013, The Journal of experimental medicine.

[2]  B. Barres,et al.  Pericytes are required for blood–brain barrier integrity during embryogenesis , 2010, Nature.

[3]  Meijuan Huang,et al.  Lymphoma endothelium preferentially expresses Tim-3 and facilitates the progression of lymphoma by mediating immune evasion , 2010, The Journal of experimental medicine.

[4]  Qiang Shen,et al.  Molecular mechanisms of endothelial hyperpermeability: implications in inflammation , 2009, Expert Reviews in Molecular Medicine.

[5]  Shuhan Sun,et al.  Melittin prevents liver cancer cell metastasis through inhibition of the Rac1‐dependent pathway , 2008, Hepatology.

[6]  G. Xia,et al.  TLR4 Signaling Is Coupled to SRC Family Kinase Activation, Tyrosine Phosphorylation of Zonula Adherens Proteins, and Opening of the Paracellular Pathway in Human Lung Microvascular Endothelia* , 2008, Journal of Biological Chemistry.

[7]  K. Hayashi,et al.  Pericytes from Brain Microvessels Strengthen the Barrier Integrity in Primary Cultures of Rat Brain Endothelial Cells , 2007, Cellular and Molecular Neurobiology.

[8]  Wenlong Li,et al.  Essential Role of Endothelial Smad4 in Vascular Remodeling and Integrity , 2007, Molecular and Cellular Biology.

[9]  A. Malik,et al.  Signaling mechanisms regulating endothelial permeability. , 2006, Physiological reviews.

[10]  N. Himes,et al.  Src blockade stabilizes a Flk/cadherin complex, reducing edema and tissue injury following myocardial infarction. , 2004, The Journal of clinical investigation.

[11]  A. Rustgi,et al.  A combined syndrome of juvenile polyposis and hereditary haemorrhagic telangiectasia associated with mutations in MADH4 (SMAD4) , 2004, The Lancet.

[12]  D. Radisky,et al.  Respect Thy Neighbor! , 2004, Science.

[13]  D. Radisky,et al.  Cancer. Respect thy neighbor! , 2004, Science.

[14]  D. Darland,et al.  TGFβ is required for the formation of capillary-like structures in three-dimensional cocultures of 10T1/2 and endothelial cells , 2004, Angiogenesis.

[15]  S. Yuan,et al.  Src-dependent, neutrophil-mediated vascular hyperpermeability and beta-catenin modification. , 2002, American journal of physiology. Cell physiology.

[16]  M. Ramachandra,et al.  Restoration of transforming growth factor Beta signaling by functional expression of smad4 induces anoikis. , 2002, Cancer research.

[17]  G. Sarosi,et al.  Tyrosine phosphorylation of vascular endothelial cadherin and the regulation of microvascular permeability. , 2002, Surgery.

[18]  M. Oshimura,et al.  Suppression of the tumorigenic phenotype by chromosome 18 transfer into pancreatic cancer cell lines , 2002, Genes, chromosomes & cancer.

[19]  W. Schmiegel,et al.  Smad4 transcriptional pathways and angiogenesis , 2002, International journal of gastrointestinal cancer.

[20]  P. Barnes,et al.  Intracranial hemorrhage in infants and children with hereditary hemorrhagic telangiectasia (Osler-Weber-Rendu syndrome). , 2002, Pediatrics.

[21]  M. Goumans,et al.  Abnormal angiogenesis but intact hematopoietic potential in TGF‐β type I receptor‐deficient mice , 2001, The EMBO journal.

[22]  Michael Chopp,et al.  Src deficiency or blockade of Src activity in mice provides cerebral protection following stroke , 2001, Nature Medicine.

[23]  D. Darland,et al.  TGF beta is required for the formation of capillary-like structures in three-dimensional cocultures of 10T1/2 and endothelial cells. , 2001, Angiogenesis.

[24]  T. Furukawa,et al.  Association of poor prognosis with loss of 12q, 17p, and 18q, and concordant loss of 6q/17p and 12q/18q in human pancreatic ductal adenocarcinoma , 2000, American Journal of Gastroenterology.

[25]  P. Donahoe,et al.  Activin receptor-like kinase 1 modulates transforming growth factor-beta 1 signaling in the regulation of angiogenesis. , 2000, Proceedings of the National Academy of Sciences of the United States of America.

[26]  P. Schwartzberg,et al.  Selective requirement for Src kinases during VEGF-induced angiogenesis and vascular permeability. , 1999, Molecular cell.

[27]  B. Brooke,et al.  Defective angiogenesis in mice lacking endoglin. , 1999, Science.

[28]  C. Deng,et al.  Angiogenesis defects and mesenchymal apoptosis in mice lacking SMAD5. , 1999, Development.

[29]  B R Johansson,et al.  Pericyte loss and microaneurysm formation in PDGF-B-deficient mice. , 1997, Science.

[30]  D. W. Johnson,et al.  The activin receptor-like kinase 1 gene: genomic structure and mutations in hereditary hemorrhagic telangiectasia type 2. , 1997, American journal of human genetics.

[31]  A. Kulkarni,et al.  Defective haematopoiesis and vasculogenesis in transforming growth factor-beta 1 knock out mice. , 1995, Development.

[32]  D. W. Johnson,et al.  Endoglin, a TGF-β binding protein of endothelial cells, is the gene for hereditary haemorrhagic telangiectasia type 1 , 1994, Nature Genetics.